Related Experiment Video
Updated: Jan 20, 2026

Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
Neuroticism as a Predictor of Frailty in Old Age: A Genetically Informative Approach
Hilda Björk Daníelsdóttir1, Juulia Jylhävä, Sara Hägg
1From the Department of Medical Epidemiology and Biostatistics (Danielsdottir, Jylhävä, Hägg, Lu, Pedersen, Mosing, Lehto), Karolinska Institutet, Stockholm, Sweden; Department of Genetics and Computational Biology (Colodro-Conde, Martin), QIMR Berghofer Medical Research Institute, Brisbane, Australia; Department of Neuroscience (Mosing), Karolinska Institutet, Stockholm, Sweden; and Department of Chronic Diseases (Lehto), Institute for Health Development, Tallinn, Estonia.
Objective:
Neuroticism is associated with poor health outcomes, but its contribution to the accumulation of health deficits in old age, that is, the frailty index, is largely unknown. We aimed to explore associations between neuroticism and frailty cross-sectionally and longitudinally, and to investigate the contribution of shared genetic influences.
Methods:
Data were derived from the UK Biobank (UKB; n = 274,951), the Australian Over 50's Study (AO50; n = 2849), and the Swedish Twin Registry (Screening Across the Lifespan of Twins Study [SALT], n = 18,960; The Swedish Adoption/Twin Study of Aging [SATSA], n = 1365). Associations between neuroticism and the frailty index were investigated using regression analysis cross-sectionally in UKB, AO50, and SATSA and longitudinally in SALT (25-29 years of follow-up) and SATSA (6 and 23 years of follow-up). The co-twin control method was applied to explore the contribution of underlying shared familial factors (SALT, SATSA, AO50). Genome-wide polygenic risk scores for neuroticism were used in all samples to further assess whether common genetic variants associated with neuroticism predict frailty.
Results:
High neuroticism was consistently associated with greater frailty cross-sectionally (adjusted β [95% confidence intervals] in UKB = 0.32 [0.32-0.33]; AO50 = 0.35 [0.31-0.39]; SATSA = 0.33 [0.27-0.39]) and longitudinally up to 29 years (SALT = 0.24 [0.22-0.25]; SATSA 6 years = 0.31 [0.24-0.38]; SATSA 23 years = 0.16 [0.07-0.25]). When adjusting for underlying shared genetic and environmental factors, the neuroticism-frailty association remained significant, although decreased. Polygenic risk scores for neuroticism significantly predicted frailty in the two larger samples (meta-analyzed total β = 0.059 [0.055-0.062]).
Conclusions:
Neuroticism in midlife predicts frailty in late life. Neuroticism may have a causal influence on frailty, whereas both environmental and genetic influences, including neuroticism-associated common genetic variants, contribute to this relationship.
Related Concept Videos
06:58Frailty Assessment in an Aging Mouse Model
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
09:03Forward Genetic Approaches in Chlamydia trachomatis
04:00Identifying Frailty Using Point-of-Care Ultrasonography: Image Acquisition and Assessment
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
07:12Using Informational Connectivity to Measure the Synchronous Emergence of fMRI Multi-voxel Information Across Time

